Results 191 to 200 of about 16,341 (256)
Beyond the Surface: Investigating the Potential Mechanisms of Non-Motor Symptoms in Myasthenia Gravis. [PDF]
Eur J NeurolWang B, Liu D, Yang Y, Zhu R.
europepmc +1 more source
Atezolizumab‐induced pure red cell aplasia
British Journal of Haematology, 2021 A 45-year-old woman underwent a bone marrow biopsy for evaluation of persistent, severe transfusion-dependent normocytic anaemia, beginning approximately two months following initiation of olaparib and atezolizumab therapy for a metastatic BRCA1-mutated ...
Rory Bennett, Anna Ruskova
openaire +3 more sources
Some of the next articles are maybe not open access.
Related searches:
Related searches:
Acta Haematologica, 2021
Pure red cell aplasia (PRCA) can potentially occur after allogeneic hematopoietic stem cell transplantation (allo-HSCT) if recipient and donor ABO blood groups are mismatched, with the recipient having isoagglutinins against the donor blood group ...
I. Henig +3 more
semanticscholar +1 more source
Pure red cell aplasia (PRCA) can potentially occur after allogeneic hematopoietic stem cell transplantation (allo-HSCT) if recipient and donor ABO blood groups are mismatched, with the recipient having isoagglutinins against the donor blood group ...
I. Henig +3 more
semanticscholar +1 more source
New England Journal of Medicine, 1973
Pure red cell aplasia (PRCA) was first described by Kaznelson (1922) as an anemia due to an almost complete cessation of erythropoiesis, but without leukopenia or thrombocytopenia. This condition usually can be clearly distinguished from aplastic anemia in which low blood white cell and platelet concentrations accompany the anemia (Van Der Weyden and ...
Howard L. Bleich +2 more
openaire +2 more sources
Pure red cell aplasia (PRCA) was first described by Kaznelson (1922) as an anemia due to an almost complete cessation of erythropoiesis, but without leukopenia or thrombocytopenia. This condition usually can be clearly distinguished from aplastic anemia in which low blood white cell and platelet concentrations accompany the anemia (Van Der Weyden and ...
Howard L. Bleich +2 more
openaire +2 more sources
Alemtuzumab induced red cell aplasia and other immune cytopenias - not so 'pure'.
Immunotherapy, 2021We report on the presentation and outcome of a 28-year-old female who developed red cell aplasia following alemtuzumab therapy for relapsing remitting multiple sclerosis.
L. Aitken +3 more
semanticscholar +1 more source
Nihon rinsho. Japanese journal of clinical medicine, 1978
Complete or near complete remission of acquired pure red cell aplasia, not associated with thymoma, occurred in response to prednisone (six occasions), prednisone and cyclophosphamide (twice), cyclophosphamide alone (once) and splenectomy (once).
T, Hoshino, T, Takahashi
openaire +3 more sources
Complete or near complete remission of acquired pure red cell aplasia, not associated with thymoma, occurred in response to prednisone (six occasions), prednisone and cyclophosphamide (twice), cyclophosphamide alone (once) and splenectomy (once).
T, Hoshino, T, Takahashi
openaire +3 more sources
Niraparib-induced pure red cell aplasia
Journal of Oncology Pharmacy Practice, 2023Introduction Niraparib, a strong poly(adenosine diphosphate-ribose) polymerase (PARP) inhibitor, contributed significantly to progression-free survival as a maintenance therapy in the platinum-sensitive period in both first-line and recurrent ovarian cancer, regardless of the BRCA mutation.
Kadriye Bir Yücel +7 more
openaire +3 more sources